Global Thrombosis Drug Market

Infograph - Global Thrombosis Drug Market

Global Thrombosis Drug Market is expected to grow at a CAGR of 9.63% over the Forecast Period of 2019– 2025

The Global Thrombosis Drugs Market is expected to grow at a CAGR of 9.63% between 2019 and 2025 in terms of value. The various disease conditions treated with thrombosis drugs include pulmonary embolism, deep vein thrombosis (DVT), and atrial fibrillation. DVT occurs more commonly in older people. Some researchers have suggested that there may be a risk from smoking and from varicose veins. These drugs, also called anticoagulants, are the most common treatment for DVT. They can keep a clot from growing or breaking off, and they prevent new clots from forming. But they can't thin your blood, despite their name, or dissolve an existing clot.


The global thrombosis drug market is primarily driven by the growing prevalence and the increasing awareness of thrombosis. Moreover, the increasing number of pipeline products and product approvals are expected to fuel market growth in the near future. However, the High cost of thrombosis drugs is expected to hinder the demand for the global thrombosis drug market. Nonetheless, the introduction of novel oral anticoagulants is anticipated to create a new opportunity for the global thrombosis drug market.